Trial Profile
Mechanism of the Effect of Alirocumab on Lipoprotein(a) Metabolism in Subjects with Inherited Elevation in Lipoprotein(a)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 May 2022
Price :
$35
*
At a glance
- Drugs Alirocumab (Primary)
- Indications Hyperlipoproteinaemia
- Focus Therapeutic Use
- Acronyms LIPAMAB
- Sponsors Linear Clinical Research
- 01 Jun 2022 Results published in the Journal of Internal Medicine
- 21 Oct 2019 Status changed from recruiting to completed.
- 26 Jun 2019 Planned End Date changed from 30 Jun 2019 to 31 Dec 2019.